New York, NY (PRWEB) September 13, 2013
Parker Waichman LLP, a national law firm dedicated to protecting the rights of victims injured by dangerous drugs and defective medical devices, has filed a lawsuit on behalf of a Virginia woman who alleges that a transvaginal mesh implant seriously injured her. The suit was filed on July 10, 2013, in the U.S. District Court for the Southern District of West Virginia (Case No. 2:13-cv-18634) in the Multidistrict Litigation (MDL) entitled In re: C. R. Bard, Inc. Pelvic System Products Liability Litigation, MDL No. 2187. C.R. Bard, Inc., and Sofradim Production SAS have been named as Defendants.
According to the Complaint, the Plaintiff was implanted with the Uretex TO Trans-obturator Urethral Support System on July 25, 2005. The implant was supposed to help treat stress urinary incontinence (SUI) and pelvic organ prolapse (POP), conditions caused by the weakening of the pelvic wall. Transvaginal mesh products are designed to help support the pelvic wall. The lawsuit, however, alleges that the mesh device was defective and had a flawed design that caused serious, and possibly permanent, injuries. The suit further alleges that the Defendants knew about the dangers of their product but chose not to warn consumers.
Thousands of transvaginal mesh lawsuits have been formulated into six MDLs pending in U.S. District Court for the Southern District of West Virginia. The list is comprised of In Re: Ethicon, Inc., Pelvic Repair Systems Products Liability Litigation, MDL No. 2327; In Re: American Medical Systems, Inc., Pelvic Repair Systems Products Liability Litigation, MDL No. 2325; In Re: C.R. Bard, Inc., Pelvic Repair Systems Products Liability Litigation, MDL No. 2187; In Re: Boston Scientific Corp., Pelvic Repair Systems Products Liability Litigation, MDL No. 2326; In Re: Coloplast Corp., Pelvic Support Systems Products Liability Litigation, MDL No. 2387; and In Re Cook Medical, Inc., Pelvic Repair System Products Liability Litigation, MDL No. 2440.
The U.S. Food and Drug Administration (FDA) reported on July 13, 2011, that the most common complications associated with transvaginal mesh may include:
The FDA also stated that complications linked to transvaginal mesh implants are “not rare” and warned that use of such devices may actually be more harmful compared to alternative methods for treating pelvic organ prolapse (POP).
The first two bellwether trials in the C.R. Bard MDL ended in favor of the Plaintiffs, according to court documents. In the second bellwether, the parties agreed to settle for an undisclosed amount, according to court documents. The trial began, and was settled on, the same date, Aug. 21, 2013, in the U.S. District Court for the Southern District of West Virginia, Charleston Division (Queen v. C.R. Bard Inc., Case No. 2:11-cv-00012).
That settlement occurred about one week after another federal jury awarded a total of $2 million in damages to a Georgia woman, having found that C.R. Bard Inc. had failed to warn of the potential dangers associated with its Avaulta-branded vaginal mesh device, according to court documents. On Thursday, Aug. 15, 2013, the jurors awarded the woman $250,000 in compensatory damages and $1.75 million in punitive damages. The trial had begun on July 29, in the U.S. District Court for the Southern District of West Virginia, Charleston Division (Cisson v. C.R. Bard Inc., Case No. 2:11-cv-00195).
Parker Waichman LLP continues to offer free lawsuit consultations to victims of transvaginal mesh injuries. If you or a loved one experienced complications following POP and SUI surgery with mesh, please visit the firm's transvaginal mesh injury page at yourlawyer.com. Free case evaluations are also available by calling 1-800-LAW-INFO (1-800-529-4636).
Parker Waichman LLP
Gary Falkowitz, Managing Attorney
1+ (800) LAW-INFO
1+ (800) 529-4636